Skip to content

Gel-One

by Seikagaku Corp.

PMA P080020

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P080020↗

FDA record

Trust

Unverified

Source FDA PMA, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP080020 Date22 Mar 2011ApprovedStatusActive

Official records

From the FDA record

FDA PMA P080020

Received by the FDA
31 Jul 2008
FDA decision
22 Mar 2011
FDA review time
964 days from receipt to decision
Docket number
11M-0198
Approval order statement, verbatim
APPROVAL FOR THE GEL-ONE. THE DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS (OA) OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO NON-PHARMACOLOGIC THERAPY, NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) OR ANALGESICS, E.G., ACETAMINOPHEN.

From the FDA PMA record P080020 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic name
Acid, hyaluronic, intraarticular
PMA number
FDA product code
MOZ
Device class
Class III
Advisory committee
Orthopedic
FDA decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Gel-One is a hyaluronic acid intra-articular injection indicated for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (NSAIDs), or analgesics such as acetaminophen. It is a sterile, single-use device designed for intra-articular administration.

The device is supplied as a pre-filled syringe for use in clinical settings by healthcare professionals. It is intended for single-use only and must be stored according to manufacturer specifications. Gel-One has received FDA PMA authorization (P080020) and is classified under product code MOZ.

Devices cleared under P080020

2 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under P080020
UDI-DISize and differences
Gel-One® Cross-linked Hyaluronate 00-1111-001-00
SEIKAGAKU CORPORATION
00-1111-001-00 / 00-1111-001-0004987541300911 —On the market
Gel-One® Cross-linked Hyaluronate 00-1111-001-00
SEIKAGAKU CORPORATION
00-1111-001-00 / 00-1111-001-0000087541300912 —No longer on the market

Similar devices

Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).

Other devices from Seikagaku Corp.